Certara, Inc. (CERT)
NASDAQ
Closed
Aug 25, 2026
Day's Range
7.9652 wk Range
4.45Overview - CERT - Certara, Inc.
Key Statistics
Valuation
Enterprise Value
1.40B
P/E (Trailing)
‪105.00‬
P/E (Forward)
‪21.12‬
PEG Ratio
‪0.03‬
Price / Sales (TTM)
‪2.98‬
Price / Book
‪1.30‬
EV / EBITDA
‪14.88‬
Profitability
Gross Margin
‪62.34%‬
Profit Margin
‪-16.21%‬
Operating Margin
‪-0.21%‬
Return on Assets
‪0.76%‬
Return on Equity
‪-2.20%‬
Ownership
Shares Outstanding
152.49M
Float
111.95M
Short % of Shares Outstanding
‪29.63%‬
Held by Insiders
‪2.72%‬
Held by Institutions
‪113.00%‬
Price stats
Beta
‪1.40‬
50-Day Avg
‪7.07‬
200-Day Avg
‪7.28‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
12 analysts
Average price target
‪$ 8.19‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CERT - Certara, Inc.
Peers - CERT - Certara, Inc.
Peer Comparison
Compared with companies in Health Information Services listed on NASDAQ.
- CERTNASDAQCertara, Inc.1.28BMarket Cap-28.23%52-week change105.00P/E (Trailing)‪-16.21%‬Profit Margin
- TEMNASDAQTempus AI, Inc.11.93BMarket Cap-10.40%52-week change39.30P/E (Trailing)‪-17.76%‬Profit Margin
- BTSGNASDAQBrightSpring Health Services, Inc.11.32BMarket Cap+58.12%52-week change53.12P/E (Trailing)‪2.54%‬Profit Margin
- HQYNASDAQHealthEquity Inc.8.81BMarket Cap+15.25%52-week change39.48P/E (Trailing)‪17.25%‬Profit Margin
- TXGNASDAQ10x Genomics Inc.8.31BMarket Cap+78.01%52-week change-182.23P/E (Trailing)‪-12.17%‬Profit Margin
- MMEDNASDAQMiniMed Group, Inc.5.60BMarket Cap+7.27%52-week change-15.30P/E (Trailing)‪-10.73%‬Profit Margin
- WAYNASDAQWaystar Holding Corp.4.86BMarket Cap-46.59%52-week change35.73P/E (Trailing)‪11.17%‬Profit Margin
Profile Summary - CERT - Certara, Inc.
About
Certara, Inc. is a global leader in biosimulation science, technology, and consulting services that transform drug development through model-informed drug development (MIDD). The company provides proprietary biosimulation platforms, software products, and expert consulting services designed to help biopharmaceutical…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
